UC San Diego Researchers Shortlisted for International Cancer Competition |
Team CAUSE, led by Moores Member Ludmil Alexandrov, PhD, and Team Biologia Ex Machina, featuring Co-Investigator and Moores Member Trey Ideker, PhD, have both made the final stage shortlist of the Cancer Grand Challenges selection process. Twelve global multidisciplinary teams now are in the final stretch to receive up to £20M, with the aim of delivering breakthroughs that no single researcher, lab, institute, or country could achieve alone.
Learn More >>
|
Moores Members Awarded CIRM Grant for Transplant Study |
|
|
Nicole Coufal, MD, PhD (Structural and Functional Genomics Research Program) and Hojun Li, MD, PhD (Hematologic Malignancies Research Program) have received a grant from the California Institute for Regenerative Medicine to develop novel approaches for delivering therapeutic myeloid cells to the brain using minimally toxic methods, which can be applied to neurodegenerative disorders and brain tumors.
|
Lifesaving Surgery Leads to Generous Kidney Donation |
After a tumor was found during a kidney donor screening, Bruce Paul Allen underwent complex lifesaving pancreatic surgery at UC San Diego Health, known as the Whipple procedure, which was made possible by early detection and the surgical expertise of Moores Member Andrew Lowy, MD, FACS (Solid Tumor Therapeutics Research Program). A year later, Allen became the hospital’s first patient to donate a kidney following this procedure, which illustrates the power of early detection, survivorship, and community engagement through organ donation. Allen now advocates for pancreatic cancer awareness and the lifesaving potential of living donation.
Read More>>
|
| |
Haydee Ojeda-Fournier, MD Site PI for National PCORI Study |
UC San Diego Health is part of a new national research collaboration, led by UCLA and funded by the Patient-Centered Outcomes Research Institute, to evaluate the use of AI in breast cancer screening. Moores Member Dr. Haydee Ojeda-Fournier, Grillo-Marxuach Family Endowed Medical Director in Breast Imaging at UC San Diego Health, serves as Site PI. This study highlights the essential role UC San Diego Health plays in advancing patient-centered approaches to early cancer detection.
Learn More >>
|
|
|
Advances in Breast Cancer: A Multidisciplinary Case-Based Conference |
Date: Saturday, October, 2025
Time: 8:00 a.m. to 2:30 p.m.
Place: The Alexandria at Torrey Pines, La Jolla, CA
This conference will showcase recent clinical advances in breast oncology that have emerged from presentations at recent international meetings, which include those held by ASCO, ESMO, and SABCS. The conference format will promote interaction between UC San Diego faculty and conference attendees, with the aim of implementing new standards of patient care and advancing clinical practice. Participants will gain up-to-date, practical information with immediate clinical application.
Register Now >>
|
Date: Sunday, October 12, 2025 to Tuesday, October 14, 2025
Place: The Estancia, La Jolla, CA
This year’s symposium, If You Could Change One Thing: Bold Ideas for Reimagining Organ Donation and Transplantation, looks to bring together manifold voices and interdisciplinary ideas to shape the future of organ donation and transplantation. Topics will include emerging technologies, public engagement, and building trust in the system. Central to the symposium will be the role of compassion—and the growing science behind it—in shaping more holistic and effective practices. Lasting change requires both structural innovation and human connection.
Register Now >>
|
|
|
FEATURED FUNDING OPPORTUNITIES |
View featured limited submission, federal, and non-federal grant and funding opportunities. |
American Cancer Society (ACS) Institutional Research Grant 2026 |
Moores Member Michael Bouvet, MD, Member of the Local Committee of the ACS Institutional Research Grant (ACS-IRG-24-1317140-51-IRG), is pleased to announce the availability of seed money to stimulate cancer research projects of high merit among junior investigators at UC San Diego.
|
|
|
| Alcohol consumption and upper aerodigestive tract squamous cell carcinoma: Evidence from 28 prospective cohorts |
Journal of the National Cancer Institute
|
Maria Elena Martinez, PhD (Cancer Control)
|
|
|
| Synthesis and Structure-Activity Relationships of CRBN-Recruiting ZBTB11 Molecular Glue Degraders
|
Journal of Medicinal Chemistry
|
Fleur M. Ferguson, PhD (Cancer Biology and Signaling)
|
|
|
| Development of Macrocyclic Peptide-Based Proteasome Inhibitors with Enhanced Blood-Brain Barrier Penetration for Treating Brain Neoplasms
|
Journal of Medicinal Chemistry
|
William H. Gerwick, PhD (Solid Tumor Therapeutics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
|
|
PYX-201-102: A Phase I/II, Open-label, Global, Multicenter, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX201 in Combination with Pembrolizumab in Participants with Advanced Solid Tumors
PI: Peter Vu, MD
NCT ID: NCT06795412
|
|
|
|
